References

Unresolved reference

External reference

Unresolved reference

External reference

Glycolysis inhibition affects proliferation and cytotoxicity of Vγ9Vδ2 T cells expanded for adoptive cell therapy

10.1016/j.jcyt.2024.04.072 · 2024 · External reference

Delta One T cells for immunotherapy of chronic lymphocytic leukemia: clinical-grade expansion/differentiation and preclinical proof of concept

10.1158/1078-0432.ccr-16-0597 · 2016 · External reference

Chimeric antigen receptor T cell immunotherapy for autoimmune rheumatic disorders: where are we now?

10.3390/cells14161242 · 2025 · External reference

bibliometrix: An R-tool for comprehensive science mapping analysis

10.1016/j.joi.2017.08.007 · 2017 · External reference

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

10.1126/science.285.5428.727 · 1999 · External reference

Single-cell RNA sequencing of human breast tumour-infiltrating immune cells reveals a γδ T-cell subtype associated with good clinical outcome

10.26508/lsa.202000680 · 2020 · External reference

Cross-presenting human γδ T cells induce robust CD8+ αβ T cell responses

10.1073/pnas.0810059106 · 2009 · External reference

Chimeric antigen receptor-engineered human gamma delta T cells: enhanced cytotoxicity with retention of cross presentation

10.1016/j.ymthe.2017.12.001 · 2018 · External reference

NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions

10.1016/j.celrep.2021.109871 · 2021 · External reference

CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature

10.1002/asi.20317 · 2006 · External reference

Gammadelta (γδ) T lymphocytes do not impact the development of early atherosclerosis

10.1016/j.atherosclerosis.2014.03.007 · 2014 · External reference

A cell for the ages: human γδ T cells across the lifespan

10.3390/ijms21238903 · 2020 · External reference

Unresolved reference

External reference

IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis

10.1038/nature14282 · 2015 · External reference

Ectopically expressed human tumor biomarker MutS homologue 2 is a novel endogenous ligand that is recognized by human γδ T cells to induce innate anti-tumor/virus immunity

10.1074/jbc.m111.327650 · 2012 · External reference

γδ T cells support pancreatic oncogenesis by restraining αβ T cell activation

10.1016/j.cell.2016.07.046 · 2016 · External reference

Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell-mediated antitumor immune response

10.1126/scitranslmed.abj0835 · 2021 · External reference

Clinical applications of gamma delta T cells with multivalent immunity

10.3389/fimmu.2014.00636 · 2014 · External reference

Off-the-shelf’ allogeneic CAR T cells: development and challenges

10.1038/s41573-019-0051-2 · 2020 · External reference

Epithelia use butyrophilin-like molecules to shape organ-specific γδ T cell compartments

10.1016/j.cell.2016.08.030 · 2016 · External reference

How to conduct a bibliometric analysis: an overview and guidelines

10.1016/j.jbusres.2021.04.070 · 2021 · External reference

A simple and robust single-step method for CAR-Vδ1 γδT cell expansion and transduction for cancer immunotherapy

10.3389/fimmu.2022.863155 · 2022 · External reference

Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells

10.1084/jem.20021500 · 2003 · External reference

Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells

10.1126/science.279.5357.1737 · 1998 · External reference

γ9 and δ2CDR3 domains regulate functional avidity of T cells harboring γ9δ2TCRs

10.1182/blood-2012-05-432427 · 2012 · External reference

Current concerns and future directions of large language model ChatGPT in medicine: a machine-learning-driven global-scale bibliometric analysis

10.1097/js9.0000000000003668 · 2026 · External reference

Artificial intelligence AlphaFold model for molecular biology and drug discovery: a machine-learning-driven informatics investigation

10.1186/s12943-024-02140-6 · 2024 · External reference

Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset

10.1182/blood-2012-05-430470 · 2012 · External reference

γδ T cell update: adaptive orchestrators of immune surveillance

10.4049/jimmunol.1800934 · 2019 · External reference

TCRγ4δ1-engineered αβT cells exhibit effective antitumor activity

10.2119/molmed.2016.00023 · 2016 · External reference

Improved survival with ipilimumab in patients with metastatic melanoma

10.1056/nejmoa1003466 · 2010 · External reference

Unresolved reference

External reference

Flanking V and J sequences of complementary determining region 3 of T-cell receptor (TCR) δ1 (CDR3δ1) determine the structure and function of TCRγ4δ1

10.1074/jbc.m111.239624 · 2011 · External reference

Metabolic reprogramming of interleukin-17-producing γδ T cells promotes ACC1-mediated de novo lipogenesis under psoriatic conditions

10.1038/s42255-025-01276-z · 2025 · External reference

Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma

10.1007/s00262-006-0199-6 · 2007 · External reference

The NKG2D ligand ULBP4 binds to TCRγ9/δ2 and induces cytotoxicity to tumor cells through both TCRγδ and NKG2D

10.1182/blood-2008-12-196287 · 2009 · External reference

Stimulation of γδ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma

10.1182/blood.v96.2.384.013k07_384_392 · 2000 · External reference

Cutting edge: bispecific γδ T cell engager containing heterodimeric BTN2A1 and BTN3A1 promotes targeted activation of Vγ9Vδ2+ T cells in the presence of costimulation by CD28 or NKG2D

10.4049/jimmunol.2200185 · 2022 · External reference

Engineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapy

10.1371/journal.pone.0051805 · 2013 · External reference

A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2 T cells for the treatment of CD1d-expressing hematological malignancies

2023 · External reference

Unresolved reference

External reference

Scoping studies: advancing the methodology

10.1186/1748-5908-5-69 · 2010 · External reference

Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patient

10.1038/s41467-024-45449-y · 2024 · External reference

Bibliometric analysis of γδ T cells as immune regulators in cancer prognosis

2022 · External reference

Distinct metabolic programs established in the thymus control effector functions of γδ T cell subsets in tumor microenvironments

10.1038/s41590-020-00848-3 · 2021 · External reference

Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma

10.1136/jitc-2021-003441 · 2021 · External reference

Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia

10.1056/nejmoa1709866 · 2018 · External reference

Phase I/II trial of LAVA-1207, a novel bispecific gamma-delta T-cell engager alone, or with low dose IL-2 or pembrolizumab, in metastatic castration resistant prostate cancer (mCRPC)

10.1200/jco.2024.42.16_suppl.tps2672 · 2024 · External reference

The γδTCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness

10.1038/s41590-018-0253-5 · 2018 · External reference

Glucose metabolism controls human γδ T-cell-mediated tumor immunosurveillance in diabetes

10.1038/s41423-022-00894-x · 2022 · External reference

Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma

10.1056/nejmoa1707447 · 2017 · External reference

Allogeneic CD20-targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B-cell lymphoma models

10.1002/cti2.1373 · 2022 · External reference

Tumor-restricted activation of Vγ9Vδ2 T cells via bispecific Evobodies: a novel strategy for safe and potent immunotherapy in ovarian cancer

2025 · External reference

Function of γδ T cells in tumor immunology and their application to cancer therapy

10.1038/s12276-021-00576-0 · 2021 · External reference

Human Vδ2 T cells are a major source of interleukin-9

10.1073/pnas.1607136113 · 2016 · External reference

Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes

10.1073/pnas.1818488116 · 2019 · External reference

Systematic analysis of human colorectal cancer scRNA-seq revealed limited pro-tumoral IL-17 production potential in gamma delta T cells

10.1016/j.neo.2024.101072 · 2024 · External reference

Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells

10.1126/science.aay5516 · 2020 · External reference

Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia

10.3389/fimmu.2020.01347 · 2020 · External reference

Management of immune-related adverse events in patients treated with chimeric antigen receptor T-cell therapy: ASCO guideline

10.1200/jco.21.01992 · 2021 · External reference

Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies

10.1038/s41573-019-0038-z · 2020 · External reference

Mechanisms of resistance to CAR T cell therapy

2019 · External reference

γδ T cells in cancer

10.1038/nri3904 · 2015 · External reference

Dysfunctional tumor-infiltrating Vδ1+ T lymphocytes in microsatellite-stable colorectal cancer

10.1038/s41467-024-51025-1 · 2024 · External reference

GMP-grade manufacturing of T cells engineered to express a defined γδTCR

10.3389/fimmu.2018.01062 · 2018 · External reference

β-Catenin drives butyrophilin-like molecule loss and γδ T-cell exclusion in colon cancer

10.1158/2326-6066.cir-22-0644 · 2023 · External reference

Natural and synthetic non-peptide antigens recognized by human γδ T cells

10.1038/375155a0 · 1995 · External reference

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

10.1056/nejmoa1200690 · 2012 · External reference

PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation

10.7326/m18-0850 · 2018 · External reference

Human Vγ9/Vδ2 T cells: innate adaptors of the immune system

10.1016/j.cellimm.2015.01.008 · 2015 · External reference

Software survey: VOSviewer, a computer program for bibliometric mapping

10.1007/s11192-009-0146-3 · 2010 · External reference

Six-of-the-best: unique contributions of γδ T cells to immunology

10.1038/nri3384 · 2013 · External reference

γδT cells are prevalent in the proximal aorta and drive nascent atherosclerotic lesion progression and neutrophilia in hypercholesterolemic mice

10.1371/journal.pone.0109416 · 2014 · External reference

A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid Leukemia

10.1016/j.clml.2023.02.003 · 2023 · External reference

Anti-PD-1 antibody armored γδ T cells enhance anti-tumor efficacy in ovarian cancer

10.1038/s41392-023-01646-7 · 2023 · External reference

γδ T cells for immune therapy of patients with lymphoid malignancies

10.1182/blood-2002-12-3665 · 2003 · External reference

Butyrophilin-like 3 directly binds a human Vγ4+ T cell receptor using a modality distinct from clonally-restricted antigen

10.1016/j.immuni.2019.09.006 · 2019 · External reference

Lysis of a broad range of epithelial tumour cells by human γδ T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition

10.1111/j.1365-3083.2007.01963.x · 2007 · External reference

An innate-like Vδ1+ γδ T cell compartment in the human breast is associated with remission in triple-negative breast cancer

10.1126/scitranslmed.aax9364 · 2019 · External reference

The role of γδ T lymphocytes in atherosclerosis

2024 · External reference

γδ T-cell autoresponses to ectopic membrane proteins: a new type of pattern recognition

10.1038/s41423-025-01258-x · 2025 · External reference

Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cells

10.1038/s41586-023-06525-3 · 2023 · External reference

CDR3δ-grafted γ9δ2T cells mediate effective antitumor reactivity

10.1038/cmi.2011.28 · 2012 · External reference

γδ T cells: Major advances in basic and clinical research in tumor immunotherapy

10.1097/cm9.0000000000002781 · 2024 · External reference

Bibliometric methods in management and organization

10.1177/1094428114562629 · 2015 · External reference